Coincidental Detection of Gastrointestinal Stromal Tumors During Laparoscopic Bariatric Procedures—Data and Treatment Strategy of a German Reference Center
- 28 Downloads
Intraoperative pathologic findings during bariatric surgery are relatively rare. Gastrointestinal stromal tumors (GISTs) are commonly located in the stomach and account for < 1% of all neoplasms of the alimentary tract. Coincidental detection of GISTs during bariatric surgery has been reported around 0.8%. We analyzed the incidence of GISTs in bariatric patients and investigated whether simultaneous resection can be oncologically adequate.
A single-center retrospective study of 707 morbidly obese patients, who underwent bariatric surgery (either Roux-en-Y gastric bypass (RYGB), One Anastomosis Gastric Bypass (OAGB), or sleeve resection (LSG) between January 2012 and August 2018). Intraoperative incidental GISTs were recorded and documented for tumor size, localization, immunoreactivity, and mitotic index.
Nine (1.27%) patients were identified with GISTs. Seven (78%) tumors were detected in women; mean age 55.6 (range 27–74), mean BMI 51.7 mg/m2 (range 38–71). GISTs were predominantly located in the stomach (78%) and two (22%) within the small bowel; six were found during RYGB vs. three during LSG. No abort of surgery or change of the intended procedure was necessary. All tumors (0.2–3.7 cm) were resected with disease-free surgical margins and displayed low malignancy. No adjuvant therapy was necessary.
The incidence of incidental GISTs in our series was higher to what has already been reported. Risk of malignancy was low and resection as part of the bariatric procedure was considered as definitive treatment. Suspicious tumors should be removed and confirmed by histology. In case of GIST histology, tumor resection with negative margins may be weighed as complete oncological treatment if there is low risk of malignancy.
KeywordsGIST Bariatric surgery Incidental finding Laparoscopy
This work was supported by the “Clinician Scientist Program” provided from the Medical Faculty of University of Leipzig to Mr. Orestis Lyros.
Compliance with Ethical Standards
Statement Regarding Ethics and Consent
For this type of study, formal consent is not required.
Conflict of Interest
The authors declare that they have no conflict of interest.
- 23.Walędziak M, Różańska-Walędziak A, Kowalewski PK, et al. Bariatric surgery and incidental gastrointestinal stromal tumors—a single-center study: VSJ competition, 1st place. Wideochir Inne Tech Maloinwazyjne. 2017;12(3):325–9.Google Scholar
- 27.Makris MC, Alexandrou A, Papatsoutsos EG, et al. Ghrelin and obesity: identifying gaps and dispelling myths. A Reappraisal In Vivo. 2017;31(6):1047–50.Google Scholar
- 31.Koch S, Besuch P. Gastrointestinal stromal tumors – retrospective classification of mesenchymal tumors of the gastrointestinal tract. DGHO 2003 [Abstract].Google Scholar
- 43.Gastrointestinal stromal tumours: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up Ann 2PG, Abecassis N, Aro HT, et al. Gastrointestinal stromal tumours: ESMO-EURACAN clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Supplement_4):iv267.Google Scholar
- 44.Huang Z, Li Y, Zhao H, et al. Prognositic factors and clinicopathologic characteristics of small gastrointestinal stromal tumor of the stomach: a retrospective analysis of 31 cases in one center. Cancer Biol Med. 2013;10(3):165–8.Google Scholar
- 45.D’Ambrosio L, Palesandro E, Boccone P, et al. Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour. Eur J Cancer. 2017;78:122–32.Google Scholar